LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
42
Frequently Asked Questions
What is Market Cap of LENZ Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. LENZ Therapeutics Inc. market cap is $1.14B.
What is the 52-week high for LENZ Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. LENZ Therapeutics Inc. 52 week high is $41.70 as of September 05, 2025.
What is the 52-week low for LENZ Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. LENZ Therapeutics Inc. 52 week low is $16.54 as of September 05, 2025.
What is LENZ Therapeutics Inc. stock price today?
LENZ Therapeutics Inc. stock price today is $41.98.
What was LENZ Therapeutics Inc. stock price yesterday?
LENZ Therapeutics Inc. stock price yesterday was $39.92.
What is the PE ratio of LENZ Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. LENZ Therapeutics Inc.’s P/E ratio is -21.03.
What is the Price-to-Book ratio of LENZ Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. LENZ Therapeutics Inc. P/B ratio is 5.5132.
What is the 50-day moving average of LENZ Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. LENZ Therapeutics Inc. 50-day moving average is $34.47.
How many employess does LENZ Therapeutics Inc. has?